A San Francisco behavioral- and mental-health clinic implementing programming and services focused on Black residents is ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

You might not think that there's a link between the state where you reside and your risk of death from cancer. Interestingly, ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

Joni Roberts, a public health assistant professor and global health advocate at Cal Poly, is among three faculty members to ...

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...

Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

"People who suffer from sickle cell have challenges that I don't believe we all know," Philpart said. "Sometimes it gets lost ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact and the latest medical perspectives.

Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...